Economic analysis of the global polio eradication initiative

Vaccine

Volumn 29, Issue 2, 2010, Pages 334-343

  Duintjer Tebbens, Radboud J ^a,b   Pallansch, Mark A ^c   Cochi, Stephen L ^c   Wassilak, Steven G F ^c   Linkins, Jennifer ^d   Sutter, Roland W ^d   Aylward, R Bruce ^d   Thompson, Kimberly M ^a  

^a Kid Risk Inc   (United States)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cost benefit analysis; Cost effectiveness analysis; Polio eradication; Vaccination

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; RETINOL;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; FOLLOW UP; HEALTH CARE COST; HEALTH ECONOMICS; INFECTION CONTROL; LOWEST INCOME GROUP; PARALYSIS; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION;

COST-BENEFIT ANALYSIS; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; POLIOMYELITIS; POLIOVIRUS VACCINES; VACCINATION;

EID: 78649717696     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.026     Document Type: Article

References (71)

1. Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D. Smallpox and its eradication 1988, World Health Organization, Geneva, Switzerland.
2. de Quadros C.A., Andrus J.K., Olive J.-M., Guerra de Macedo C., Henderson D.A. Polio eradication from the Western Hemisphere. Annual Reviews of Public Health 1992, 13:239-252.
3. World Health Assembly Global eradication of poliomyelitis by the year 2000 (resolution 41.28) 1988, World Health Organization, Geneva.
4. Aylward R.B., Acharya A., England S., Agocs M., Linkins J. Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet 2003, 362(9387 (September 13)):909-914.
5. Barrett S. Global disease eradication. Journal of the European Economic Association 2003, 1(2/3 (April/May)):591-600.
6. Thompson K.M., Duintjer Tebbens R.J., Pallansch M.A., Kew O.M., Sutter R.W., Aylward R.B., et al. The risks, costs, and benefits of global policies for managing polio after eradication. American Journal of Public Health 2008, 98(7 (July)):1322-1330.
7. World Health Assembly Poliomyelitis: mechanism for management of potential risks to eradication (resolution 61.1) 2008, World Health Organization, Geneva.
8. Sangrujee N., Duintjer Tebbens R.J., Cáceres V.M., Thompson K.M. Policy decision options during the first 5 years following certification of polio eradication. Medscape General Medicine 2003, 5(4 (December 18)):35.
9. Duintjer Tebbens R.J., Sangrujee N., Thompson K.M. The costs of polio risk management policies after eradication. Risk Analysis 2006, 26(6 (December)):1507-1531.
10. Thompson K.M., Duintjer Tebbens R.J. Eradication versus control for poliomyelitis: an economic analysis. Lancet 2007, 369(9570 (April 21)):1363-1371.
11. Musgrove P. Is polio eradication in the Americas economically justified?. Bulletin of the Pan American Health Organization 1988, 22(1):1-16.
12. Bart K., Foulds J., Patriarca P. Global eradication of poliomyelitis: benefit-cost analysis. Bulletin of the World Health Organization 1996, 74:35-45.
13. Aylward R.B., Acharya A.K., England S., Agocs M., Linkins J. Polio eradication. Global public goods for health: health economic and public health perspectives 2003, 33-53. Oxford University Press. R. Smith, R. Beaglehole, D. Woodward, N. Drager (Eds.).
14. Kahn M.M., Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine 2003, 21:702-705.
15. Thompson K.M., Duintjer Tebbens R.J. Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Analysis 2006, 26(6 (December)):1423-1440.
16. Duintjer Tebbens R.J., Pallansch M.A., Kew O.M., Sutter R.W., Aylward R.B., Watkins M., et al. Uncertainty and sensitivity analyses of a decision analytic model for post-eradication polio risk management. Risk Analysis 2008, 28(4 (August)):855-876.
17. World Health Organization. Global Polio Eradication Initiative - Strategic Plan 2010-2012; 2010. Geneva. Report No.: WHO/Polio/10.01.
18. World Health Organization Polio eradication initiative. Cessation of routine oral polio vaccine (OPV) use after global polio eradication. framework for national policy makers in OPV-using countries 2005, Geneva, Switzerland. Report No.: WHO/POL/05.02.
19. Aylward R.B., Sutter R.W., Heymann D.L. OPV cessation - the final step to a " polio-free" world. Science 2005, 310(5748 (October 28)):625-626.
20. Duintjer Tebbens R.J., Pallansch M.A., Kew O.M., Cáceres V.M., Jafari H., Cochi S.L., et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Analysis 2006, 26(6 (December)):1471-1505.
21. Thompson K.M., Duintjer Tebbens R.J. The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation. The Medscape Journal of Medicine 2008, 10(8):190.
22. UN Population Division. World population prospects population database: the 2008 revision population database; 2010 [cited 2010 January 4]. Available from: http://esa.un.org/unpp/.
23. World Bank. Country classification; 2009 [cited 2009 June 13]. Available from: http://go.worldbank.org/K2CKM78CC0.
24. World Health Organization Polio eradication initiative external funds database 2009, Geneva, Switzerland.
25. World Health Organization. WHO/UNICEF estimated coverage time series; 2009 October [cited 2010 February 15]. Available from: http://www.who.int/entity/immunization_monitoring/data/coverage_estimates_series.xls.
26. World Health Organization. Incidence series; 2009, December 21 [cited 2010 February 15]. Available from: http://www.who.int/entity/immunization_monitoring/data/incidence_series.xls.
27. Duintjer Tebbens R.J., Pallansch M.A., Kew O.M., Cáceres V.M., Sutter R.W., Thompson K.M. A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. American Journal of Epidemiology 2005, 162(4 (August)):358-372.
28. Burton A., Monasch R., Lautenbach B., Gacic-Dobo M., Neill M., Karimov R., et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bulletin of the World Health Organization 2009, 87(7 (July)):535-541.
29. Eichner M., Dietz K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?. American Journal of Epidemiology 1996, 143(8):816-822.
30. World Health Organization. AFP case count; 2010 February 12 [cited 2010 February 15]. Available from: http://www.who.int/vaccines/immunization_monitoring/en/diseases/poliomyelitis/case_count.cfm.
31. Hull H.F., Ward N.A., Hull B.P., Milstien J., de Quadros C.A. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994, 343:1331-1337.
32. World Health Organization Poliomyelitis 1980 - part 2. Weekly Epidemiological Record 1981, 56(43 (30 October)):337-341.
33. World Health Organization. Circulating vaccine-derived poliovirus, 2000-2009; 2010 February 2 [cited 2010 February 15]. Available from: http://www.polioeradication.org/content/general/cvdpv_count.pdf.
34. Gold M.R., Siegel J.E., Russel L.B., Weinstein M.C. Cost-effectiveness in health and medicine 1996, Oxford University Press, New York.
35. World Health Organization WHO guide for standardization of economic evaluations of immunization programmes 2008, Initiative for Vaccine Research, Department of Immunization, Vaccine, and Biologicals, Geneva, December. Report No.: WHO/IVB/0814.
36. Bureau of Labor Statistics, U.S. Department of Labor. Consumer price index. June 17; 2009 [cited 2009 July 2]. Available from: ftp://ftp.bls.gov/pub/special.requests/cpi/cpiai.txt.
37. World Health Organization Details of projected GPEI external resource requirements 2009-2013 as of June 2009 2009, Geneva, Switzerland.
38. World Health Organization. Global polio eradication initiative - financial resource requirements 2010-2012 as of February 2010. Geneva; 2010. Report No.: WHO/POLIO/10.01.
39. de Gourville E.M., Sangrujee N., Duintjer Tebbens R.J., Pallansch M.A., Thompson K.M. Global surveillance and the value of information: the case of the global polio laboratory network. Risk Analysis 2006, 26(6 (December)):1557-1569.
40. World Health Organization WHO global action plan to minimize poliovirus facility-associated risk in the post-eradication/post-OPV era 2007, World Health Organization, Geneva. 3rd ed.
41. Duintjer Tebbens R.J., Pallansch M.A., Alexander J.P., Thompson K.M. Optimal vaccine stockpile design for an eradicated disease: application to polio. Vaccine 2010, 28(26 (June 11)):4312-4327.
42. Miller M.A., Sutter R.W., Strebel P.M., Hadler S.C. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. Journal of the American Medical Association 1996, 276(12):967-971.
43. Ministry of Health, Brazil. Memória sobre estimativa de custos dos casos de poliomielite no Brasil em 1982. Brasilia; 1984.
44. Tucker A.W., Isaacs D., Burgess M. Cost-effectiveness of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia. Australian and New Zealand Journal of Public Health 2001, 25(5 (July)):411-416.
45. Griffiths U., Botham L., Schoub B.D. The cost-effectiveness of alternative polio immunization policies in South Africa. Vaccine 2006, 24:5670-5678.
46. World Health Organization Commission on Macroeconomics and Health Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health 2001, World Health Organization, Geneva.
47. Hutubessy R., Chisholm D., Edejer T.T.-T. WHO-CHOICE. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation 2003, 1(1 (December 19)):8.
48. Murray C.J., Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Harvard University Press, Cambridge, MA.
49. Ching P., Birmingham M., Goodman T., Sutter R., Loevinsohn B. Childhood mortality impact and costs of integrating vitamin A supplementation into immunization campaigns. American Journal of Public Health 2000, 90(10 (October)):1526-1529.
50. Goodman T., Dalmiya N., de Benoist B., Schultink W. Polio as a platform: using national immunization days to deliver vitamin A supplements. Bulletin of the World Health Organization 2000, 78(3):305-314.
51. Gacic-Dobo M. IVB SIA database as of 21 December, 2009. Geneva; 2009.
52. Taylor C.E., Cutts F., Taylor M.E. Ethical Dilemmuas in current planning for polio eradication. American Journal of Public Health 1997, 87(6):922-925.
53. Taylor Commission The impact of the expanded programme on immunization and the polio eradication initiative on health systems in the Americas 1995, Pan American Health Organization, Washington, DC, Report No.: 1995-00003B.
54. Sutter R.W., Cochi S.L., Comment: Ethical dilemmas in worldwide polio eradication programs. American Journal of Public Health 1997, 87(6):913-915.
55. Loevinsohn B., Aylward R.B., Steinglass R., Ogden E., Goodman T., Melgaard B. Impact of targeted programs on health systems: a case study of the polio eradication initiative. American Journal of Public Health 2002, 92(1 (January)):19-23.
56. Aylward R.B., Hull H.F., Cochi S.L., Sutter R.W., Olive J.M., Melgaard B. Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bulletin of the World Health Organization 2000, 78(3):285-297.
57. Shibuya K., Murray C.J.L. Poliomyelitis. The global epidemiology of infectious diseases 2004, 111-150. World Health Organization, Geneva. C.J.L. Murray, A.D. Lopez, C.D. Mathers (Eds.).
58. Robertson S.E., Chan C., Kim-Farley R., Ward N. Worldwide status of poliomyelitis in 1986, 1987 and 1988, and plans for its global eradication by the year 2000. World Health Statistics Quarterly 1990, 43(2):80-90.
59. World Health Organization. Expanded Programme on Immunization: EPI global overview. Geneva; 1986. Report No.: EPI/GAG/86/WP.1.
60. Henderson R.H., Keja J., Hayden G., Galaka A., Clements J., Chan C. Immunizing the children of the world: progress and prospects. Bulletin of the World Health Organization 1988, 66(5):535-543.
61. Sabin A.B. Strategy for rapid elimination and continuing control of poliomyelitis and other vaccine preventable diseases of children in developing countries. British Medical Journal (Clinical Research Edition) 1986, 292(6519):513-533.
62. Tangermann R.H., Aylward R.B., Hull H.F., Nkowane B.M., Everts H., Olive J.-M. Progress towards the eradication of poliomyelitis globally and in Africa, January 2000. Médecine tropicale: revue du Corps de santé colonial 1999, 59(4 Pt 2):475-482.
63. Centers for Disease Control and Prevention Global progress toward laboratory containment of wild polioviruses, June 2001. Morbidity and Mortality Weekly Report 2001, 50(29 (July 27)):620-623.
64. Endgame issues for the global polio eradication initiative. Clinical Infectious Diseases 2002, 19(34 (November)):72-77. Technical Consultative Group of the World Health Organization on the Global Eradication of Poliomyelitis.
65. Centers for Disease Control and Prevention Progress toward interruption of wild poliovirus transmission - worldwide, January 2007-April 2008. Morbidity and Mortality Weekly Report 2008, 57(18 (May 9)):489-494.
66. Aylward R.B., Sutter R.W., Cochi S.L., Thompson K.M., Jafari H., Heymann D.L. Risk management in a polio-free world. Risk Analysis 2006, 26(6 (December)):1441-1448.
67. World Health Organization ROfE. WHO epidemiological brief: Tajikistan polio outbreak and regional response; 2010 [cited 2010 July 27]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0019/118342/EPI_TJK_Issue3.pdf.
68. Thompson K.M., Segui-Gomez M., Graham J.D. Validating benefit and cost estimates: the case of airbag regulation. Risk Analysis 2002, 22(4):803-811.
69. World Health Organization Progress towards poliomyelitis eradication in India, January 2007-May 2009. Weekly Epidemiological Record 2009, 84(28 (July 10)):281-287.
70. Dowdle W.R., Birmingham M.E. The biologic principles of poliovirus eradication. Journal of Infectious Diseases 1997, 175(Suppl. 1):S286-S292.
71. World Bank. World development indicators data query; 2009 [cited 2009 July 8]. Available from: http://devdata.worldbank.org/data-query/.